nach oben

Digestive Diseases and Sciences

Erschienen in:

01.11.2014 | Review

Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction

verfasst von: Tarun Rustagi, Priya A. Jamidar

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Self-expandable metal stents (SEMS) are the current standard of care for the palliative management of malignant biliary strictures. Recently, endoscopic ablative techniques with direct affect to local tumor have been developed to improve SEMS patency. Several reports have demonstrated the technical feasibility and safety of intraductal radiofrequency ablation (RFA), by both endoscopic and percutaneous approaches, in palliation of malignant strictures of the bile duct. Intraductal RFA has also been used in the treatment of occlusion of both covered and uncovered SEMS occlusion from tumor ingrowth or overgrowth. This article provides a comprehensive review of intraductal RFA in the management of malignant biliary obstruction.

McGorisk T, Krishnan K, Keefer L, Komanduri S. Radiofrequency ablation for refractory gastric antral vascular ectasia (with video). Gastrointest Endosc. 2013;78:584–588.PubMedCrossRef

Dray X, Repici A, Gonzalez P, et al. Radiofrequency ablation treatment of gastric antral vascular ectasia: results from an international collaborative study. Gastrointest Endosc. 1040;77:AB180.

Nikfarjam M, Faulx A, Laughinghouse M, Marks JM. Feasibility of radiofrequency ablation for the treatment of chronic radiation proctitis. Surg Innov. 2010;17:92–94.

Zhou C, Adler DC, Becker L, et al. Effective treatment of chronic radiation proctitis using radiofrequency ablation. Therap Adv Gastroenterol. 2009;2:149–156.PubMedCrossRefPubMedCentral

Rustagi T, Mashimo H. Endoscopic management of chronic radiation proctitis. World journal of gastroenterology : WJG. 2011;17:4554–4562.PubMedCrossRefPubMedCentral

Eddi R, Depasquale JR. Radiofrequency ablation for the treatment of radiation proctitis: a case report and review of literature. Therap Adv Gastroenterol. 2013;6:69–76.PubMedCrossRefPubMedCentral

Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008;40:380–387.PubMedCrossRef

Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195.PubMedCrossRef

Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141:460–468.PubMedCrossRefPubMedCentral

10.

Wolf DS, Dunkin BJ, Ertan A. Endoscopic radiofrequency ablation of Barrett’s esophagus. Surg Technol Int. 2012;22:83–89.PubMed

11.

Lin ZZ, Shau WY, Hsu C, et al. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. PLoS ONE. 2013;8:e80276.PubMedCrossRefPubMedCentral

12.

Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years) with very early or early hepatocellular carcinoma. Cancer. 2013;119:3812–3820.PubMedCrossRef

13.

Geyik S, Akhan O, Abbasoglu O, et al. Radiofrequency ablation of unresectable hepatic tumors. Diagn Interv Radiol. 2006;12:195–200.PubMed

14.

Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244:599–607.PubMedCrossRef

15.

Cirocchi R, Trastulli S, Boselli C, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012;6:CD006317.PubMed

16.

Ruers T, Punt C, Van Coevorden F, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012;23:2619–2626.PubMedCrossRefPubMedCentral

17.

Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508–520.PubMedCrossRef

18.

Weng M, Zhang Y, Zhou D, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS ONE. 2012;7:e45493.PubMedCrossRefPubMedCentral

19.

Zou YP, Li WM, Zheng F, et al. Intraoperative radiofrequency ablation combined with 125 iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol. 2010;16:5104–5110.PubMedCrossRefPubMedCentral

20.

Tang Z, Wu YL, Fang HQ, et al. Treatment of unresectable pancreatic carcinoma by radiofrequency ablation with ‘cool-tip needle’: report of 18 cases. Zhonghua yi xue za zhi. 2008;88:391–394.PubMed

21.

Hadjicostas P, Malakounides N, Varianos C, Kitiris E, Lerni F, Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB. 2006;8:61–64.PubMedCrossRefPubMedCentral

22.

Wu Y, Tang Z, Fang H, et al. High operative risk of cool-tip radiofrequency ablation for unresectable pancreatic head cancer. J Surg Oncol. 2006;94:392–395.PubMedCrossRef

23.

Carrafiello G, Lagana D, Cotta E, et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010;33:835–839.PubMedCrossRef

24.

Chiou YY, Hwang JI, Chou YH, Wang HK, Chiang JH, Chang CY. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci. 2005;21:304–309.PubMedCrossRef

25.

Fan WJ, Wu PH, Zhang L, et al. Radiofrequency ablation as a treatment for hilar cholangiocarcinoma. World J Gastroenterol. 2008;14:4540–4545.PubMedCrossRefPubMedCentral

26.

Slakey DP. Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg. 2002;68:395–397.PubMed

27.

Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol. 2005;100:2426–2430.PubMedCrossRef

28.

Zoepf T. Photodynamic therapy of cholangiocarcinoma. HPB. 2008;10:161–163.PubMedCrossRefPubMedCentral

29.

Pereira S HS, Roughton M, O’Donoghue P, Wasan H, Valle J, Bridgewater J. Photostent-02; Porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with advanced or metastatic cholangiocarcinomas and other biliary tract tumours: a multicentre, randomised phase III trial. ESMO. 2010; (Abstract No. 8020).

30.

Steel AW, Postgate AJ, Khorsandi S, et al. Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 2011;73:149–153.PubMedCrossRef

31.

Mizandari M, Pai M, Xi F, et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2013;36:814–819.PubMedCrossRef

32.

Itoi T, Isayama H, Sofuni A, et al. Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex vivo pig liver. J HepatoBiliary Pancreat Sci. 2012;19:543–547.PubMedCrossRef

33.

Mao EJ, Watson JB, Soares G, Habr FG. Successful Percutaneous Endobiliary radiofrequency ablation for unresectable malignant biliary obstruction: a case report and review of the literature. J Gastrointest Cancer. 2013; Aug 24.

34.

Khorsandi SZD, Vavra P. The modern use of radiofrequency energy in surgery, endoscopy and interventional radiology. Eur Surg. 2008;40:204–210.CrossRef

35.

Zacharoulis D, Lazoura O, Sioka E, et al. Habib EndoHPB: a novel endobiliary radiofrequency ablation device. An experimental study. J Invest Surg.. 2013;26:6–10.PubMedCrossRef

36.

Figueroa-Barojas P, Bakhru MR, Habib NA, et al. Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique. J Oncol. 2013;2013:910897.PubMedCrossRefPubMedCentral

37.

Alis H, Sengoz C, Gonenc M, Kalayci MU, Kocatas A. Endobiliary radiofrequency ablation for malignant biliary obstruction. Hepatobiliary Pancreat Dis Int. 2013;12:423–427.PubMedCrossRef

38.

Dolak W, Schreiber F, Schwaighofer H, et al. Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications. Surg Endosc. 2014;28:854–860.PubMedCrossRef

39.

Pozsár J, Tarpay Á, Burai J, Pap A. Intraductal radiofrequency ablation can restore patency of occluded biliary self-expanding metal stents. Z Gastroenterol. 2011. doi:10.1055/s-0031-1278501.

40.

Monga A, Gupta R, Ramchandani M, Rao GV, Santosh D, Reddy DN. Endoscopic radiofrequency ablation of cholangiocarcinoma: new palliative treatment modality (with videos). Gastrointest Endosc. 2011;74:935–937.PubMedCrossRef

41.

Mukund A, Arora A, Rajesh S, Bothra P, Patidar Y. Endobiliary radiofrequency ablation for reopening of occluded biliary stents: a promising technique. J Vasc Interv Radiol. 2013;24:142–144.PubMedCrossRef

42.

Pai M, Valek V, Tomas A, et al. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol. 2014;37:235–240.

Titel: Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction
verfasst von: Tarun Rustagi
Priya A. Jamidar
Publikationsdatum: 01.11.2014
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 11/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-014-3237-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Intraductal Radiofrequency Ablation for Management of Malignant Biliary Obstruction

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2014

Complications Following Liver Transplantation for Progressive Familial Intrahepatic Cholestasis

High-Definition White-Light (HDWL) Colonoscopy and Higher Adenoma Detection Rate and the Potential for Paradoxical Over Surveillance

Impaired Viscosity of Gastric Secretion and Its Mucin Content as Potential Contributing Factors to the Development of Chronic Constipation

Endoscopic Bilio-Duodenal Bypass: Outcomes of Primary and Revision Efficacy of Combined Metallic Stents in Malignant Duodenal and Biliary Obstructions

Effect of Omeprazole Dose, Nonsteroidal Anti-inflammatory Agents, and Smoking on Repair Mechanisms in Acute Peptic Ulcer Bleeding

Epidemiology of Metastatic Hepatocellular Carcinoma, A Nationwide Perspective

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin